תמונות העטיפה

Exploring the interaction between epidermal growth factor receptor tyrosine kinase and some of the synthesized inhibitors using combination of in-silico and in-vitro cytotoxicity methods

Quinazoline derivatives are potent inhibitors of human epidermal growth factor receptor (EGFR) as anticancer agents. In this study, the cytotoxic effects of a new series of synthesized quinazoline derivatives were evaluated using MTT assay against MCF-7 and HT-29 cell lines. Using molecular docking,...

תיאור מלא

שמור ב:

מידע ביבליוגרפי
Main Authors:	Rezvan Rezaee Nasab (Author), Mahboubeh Mansourian (Author), Farshid Hassanzadeh (Author), Mohsen Shahlaei (Author)
פורמט:	ספר
יצא לאור:	Wolters Kluwer Medknow Publications, 2018-01-01T00:00:00Z.
נושאים:	article
גישה מקוונת:	Connect to this object online.
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים

Synthesis, antimicrobial evaluation and docking studies of some novel quinazolinone Schiff base derivatives
מאת: Rezvan Rezaee Nasab, et al.
יצא לאור: (2018)

Docking study, synthesis and antimicrobial evaluation of some novel 4-anilinoquinazoline derivatives
מאת: Rezvan Rezaee Nasab, et al.
יצא לאור: (2017)

In-Silico Screening of Novel Synthesized Thienopyrimidines Targeting Fms Related Receptor Tyrosine Kinase-3 and Their In-Vitro Biological Evaluation
מאת: Elshaymaa I. Elmongy, et al.
יצא לאור: (2022)

Synthesis, characterization, cytotoxic screening, and density functional theory studies of new derivatives of quinazolin-4(3H)-one Schiff bases
מאת: Rezvan Rezaee Nasab, et al.
יצא לאור: (2017)

The Role of Epidermal Growth Factor Receptor Family of Receptor Tyrosine Kinases in Mediating Diabetes-Induced Cardiovascular Complications
מאת: Bara A. Shraim, et al.
יצא לאור: (2021)

Molecular profiling of TAM tyrosine kinase receptors and ligands in endometrial carcinoma: An in silico-study
מאת: Dilara Fatma Akin, et al.
יצא לאור: (2023)

Monastrol derivatives: in silico and in vitro cytotoxicity assessments
מאת: Zahra Bidram, et al.
יצא לאור: (2020)

Team Management of Skin Rash Associated with Use of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors
מאת: Katsuhiro Masago, et al.
יצא לאור: (2018)

Synthesis and In Vitro Cytotoxicity of the 4-(Halogenoanilino)-6-bromoquinazolines and Their 6-(4-Fluorophenyl) Substituted Derivatives as Potential Inhibitors of Epidermal Growth Factor Receptor Tyrosine Kinase
מאת: Malose Jack Mphahlele, et al.
יצא לאור: (2017)

Three generations of epidermal growth factor receptor tyrosine kinase inhibitors developed to revolutionize the therapy of lung cancer
מאת: Zhang H
יצא לאור: (2016)

Role of systemic antibiotics in preventing epidermal growth factor receptor: Tyrosine kinase inhibitors-induced skin toxicities
מאת: Philomena Charlotte Dsouza, et al.
יצא לאור: (2017)

A systematic review of epidermal growth factor receptor tyrosine kinase inhibitor-induced heart failure and its management
מאת: Mohammad Nawaf AlShatnawi, et al.
יצא לאור: (2022)

An in silico high-throughput screen identifies potential selective inhibitors for the non-receptor tyrosine kinase Pyk2
מאת: Meirson T, et al.
יצא לאור: (2017)

Delving into the Role of Receptor-like Tyrosine Kinase (RYK) in Cancer: In Silico Insights into Its Diagnostic and Prognostic Utility
מאת: Jessica Alejandra Zapata-García, et al.
יצא לאור: (2024)

Some novel hybrid quinazoline-based heterocycles as potent cytotoxic agents
מאת: Mahla Malekzadeh, et al.
יצא לאור: (2022)

Skin Toxicities Induced by Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and their Influence on Treatment Adjustments in Lung Cancer Patients
מאת: Ji Su Lee, et al.
יצא לאור: (2024)

Metastatic Squamous Cell Carcinoma from Lung Adenocarcinoma after Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy
מאת: Hyung Kyu Park, et al.
יצא לאור: (2017)

Adverse event profiles of epidermal growth factor receptor‐tyrosine kinase inhibitors in cancer patients: A systematic review and meta‐analysis
מאת: Xiaonan Yin, et al.
יצא לאור: (2021)

Effect of tyrosine kinase inhibitors on the cytotoxic activity against HIV-1 infection
מאת: S. Rodríguez-Mora, et al.
יצא לאור: (2017)

Benzofuran-appended 4-aminoquinazoline hybrids as epidermal growth factor receptor tyrosine kinase inhibitors: synthesis, biological evaluation and molecular docking studies
מאת: Malose J. Mphahlele, et al.
יצא לאור: (2018)

Synthesis, anticancer and apoptosis-inducing activities of quinazoline-isatin conjugates: epidermal growth factor receptor-tyrosine kinase assay and molecular docking studies
מאת: Adel S. El-Azab, et al.
יצא לאור: (2017)

Design and synthesis of some novel triazine-tyrosine hybrids as potential agents for the treatment of multiple sclerosis
מאת: Sajjad Saeidi, et al.
יצא לאור: (2022)

The human epidermal growth factor receptor (EGFR) gene in European patients with advanced colorectal cancer harbors infrequent mutations in its tyrosine kinase domain
מאת: Delvenne Philippe, et al.
יצא לאור: (2011)

Immunomodulatory Activity of Tyrosine Kinase Inhibitors to Elicit Cytotoxicity Against Cancer and Viral Infection
מאת: Núria Climent, et al.
יצא לאור: (2019)

Receptor Tyrosine Kinases and Their Signaling Pathways as Therapeutic Targets of Curcumin in Cancer
מאת: Sareshma Sudhesh Dev, et al.
יצא לאור: (2021)

Neurotrophin-3 and FLT3 Tyrosine Kinase Receptor in Perinatal Life
מאת: Ariadne Malamitsi-Puchner, et al.
יצא לאור: (2005)

Active receptor tyrosine kinases, but not Brachyury, are sufficient to trigger chordoma in zebrafish
מאת: Gianluca D'Agati, et al.
יצא לאור: (2019)

Synthesis and cytotoxic evaluation of some derivatives of triazole-quinazolinone hybrids
מאת: Farshid Hassanzadeh, et al.
יצא לאור: (2019)

Synthesis and cytotoxic evaluation of some novel diarylamide possessing quinoxalinedione based on sorafenib
מאת: Mojtaba Khandan, et al.
יצא לאור: (2018)

Protein tyrosine kinase but not protein kinase C inhibition blocks receptor induced alveolar macrophage activation
מאת: K. Pollock, et al.
יצא לאור: (1993)

Meta-Analysis of Aidi Injection and First-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Therapy in Treating Advanced Non-Small Cell Lung Cancer
מאת: Na Xiao MD, et al.
יצא לאור: (2021)

Nuclear Pore Glycoprotein 62 Genetic Variant rs9523 is Associated with Clinical Outcomes of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Lung Adenocarcinoma Patients
מאת: Park JE, et al.
יצא לאור: (2021)

Meta-Analysis of Aidi Injection and First-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Therapy in Treating Advanced Non-Small Cell Lung Cancer
מאת: Na Xiao MD, et al.
יצא לאור: (2021)

Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma
מאת: Julie Bolcaen, et al.
יצא לאור: (2021)

Receptor tyrosine kinases as a therapeutic target by natural compounds in cancer treatment
מאת: Toheeb A. Balogun, et al.
יצא לאור: (2021)

Selective inhibition of N-linked glycosylation impairs receptor tyrosine kinase processing
מאת: Elsenoor Klaver, et al.
יצא לאור: (2019)

Tyrosine kinases in rheumatoid arthritis
מאת: Kobayashi Akiko, et al.
יצא לאור: (2011)

Quinazolin-4(3H)-one based potential multiple tyrosine kinase inhibitors with excellent cytotoxicity
מאת: Tebyan O. Mirgany, et al.
יצא לאור: (2021)

Olmutinib (BI1482694/HM61713), a Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses ABCG2-Mediated Multidrug Resistance in Cancer Cells
מאת: Wei Zhang, et al.
יצא לאור: (2018)

Design and synthesis of a novel photoaffinity probe for labelling EGF receptor tyrosine kinases
מאת: You-Guang Zheng, et al.
יצא לאור: (2017)